Siri H. Strand

2.1k total citations
21 papers, 645 citations indexed

About

Siri H. Strand is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Siri H. Strand has authored 21 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 11 papers in Cancer Research. Recurrent topics in Siri H. Strand's work include Prostate Cancer Treatment and Research (16 papers), Epigenetics and DNA Methylation (8 papers) and Prostate Cancer Diagnosis and Treatment (7 papers). Siri H. Strand is often cited by papers focused on Prostate Cancer Treatment and Research (16 papers), Epigenetics and DNA Methylation (8 papers) and Prostate Cancer Diagnosis and Treatment (7 papers). Siri H. Strand collaborates with scholars based in Denmark, United States and United Kingdom. Siri H. Strand's co-authors include Karina D. Sørensen, Michael Borre, S. Høyer, Torben Ørntoft, Torben F. Ørntoft, Christa Haldrup, Helle Kristensen, Jacob Fredsøe, Martin M. Mortensen and Peter Mouritzen and has published in prestigious journals such as Cancer Research, Oncogene and Scientific Reports.

In The Last Decade

Siri H. Strand

21 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Siri H. Strand Denmark	15	443	261	241	64	33	21	645
Sishun Gan China	17	370 0.8×	212 0.8×	167 0.7×	144 2.3×	18 0.5×	29	550
Yiu Huen Tsang United States	11	558 1.3×	240 0.9×	91 0.4×	119 1.9×	42 1.3×	13	675
Jamie Sheren United States	8	313 0.7×	143 0.5×	282 1.2×	164 2.6×	23 0.7×	9	599
Domenico Albino Switzerland	13	563 1.3×	254 1.0×	181 0.8×	209 3.3×	51 1.5×	23	773
Paula Paulo Portugal	16	330 0.7×	163 0.6×	256 1.1×	106 1.7×	118 3.6×	28	596
Wilma J. Teubel Netherlands	12	253 0.6×	162 0.6×	315 1.3×	106 1.7×	93 2.8×	17	564
Tianshui Sun China	9	456 1.0×	179 0.7×	85 0.4×	137 2.1×	17 0.5×	14	556
Maria Cardenas United States	6	266 0.6×	198 0.8×	117 0.5×	214 3.3×	28 0.8×	14	496
Xiao-Song Wang United States	6	484 1.1×	439 1.7×	70 0.3×	97 1.5×	65 2.0×	7	634
Karen Sayal United Kingdom	5	225 0.5×	362 1.4×	149 0.6×	175 2.7×	43 1.3×	7	570

Countries citing papers authored by Siri H. Strand

Since Specialization

Citations

This map shows the geographic impact of Siri H. Strand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siri H. Strand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siri H. Strand more than expected).

Fields of papers citing papers by Siri H. Strand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siri H. Strand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siri H. Strand. The network helps show where Siri H. Strand may publish in the future.

Co-authorship network of co-authors of Siri H. Strand

This figure shows the co-authorship network connecting the top 25 collaborators of Siri H. Strand. A scholar is included among the top collaborators of Siri H. Strand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siri H. Strand. Siri H. Strand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qin, Xiaodi, Siri H. Strand, Marissa R. Lee, et al.. (2025). Single-Cell Expression Analysis of Ductal Carcinoma In Situ Identifies Complex Genotypic–Phenotypic Relationships Altering Epithelial Composition. Cancer Research. 85(12). 2302–2319. 1 indexed citations

Strand, Siri H., Kathleen E. Houlahan, Thomas Lynch, et al.. (2024). Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome. Breast Cancer Research. 26(1). 127–127. 1 indexed citations

Bjerre, Marianne, Ole H. Larsen, Sarah Østrup Jensen, et al.. (2020). Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential. Cells. 9(6). 1362–1362. 27 indexed citations

Strand, Siri H., Linnéa Schmidt, Michael Borre, et al.. (2020). Validation of the four-miRNA biomarker panel MiCaP for prediction of long-term prostate cancer outcome. Scientific Reports. 10(1). 10704–10704. 8 indexed citations

Strand, Siri H., Clara Cieza-Borrella, Magnus E. Jakobsson, et al.. (2020). FRMD6 has tumor suppressor functions in prostate cancer. Oncogene. 40(4). 763–776. 27 indexed citations

Bjerre, Marianne, Siri H. Strand, Helle Kristensen, et al.. (2019). Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer. International Journal of Molecular Sciences. 20(5). 1173–1173. 30 indexed citations

Strand, Siri H., Helle Kristensen, S. Høyer, et al.. (2019). A novel combined miRNA and methylation marker panel (miMe) for prediction of prostate cancer outcome after radical prostatectomy. International Journal of Cancer. 145(12). 3445–3452. 12 indexed citations

Kristensen, Gitte, Siri H. Strand, Martin Andreas Røder, et al.. (2019). 5hmC Level Predicts Biochemical Failure Following Radical Prostatectomy in Prostate Cancer Patients with ERG Negative Tumors. International Journal of Molecular Sciences. 20(5). 1025–1025. 5 indexed citations

Fredsøe, Jacob, Linnéa Schmidt, Siri H. Strand, et al.. (2019). Elevated miR-615-3p Expression Predicts Adverse Clinical Outcome and Promotes Proliferation and Migration of Prostate Cancer Cells. American Journal Of Pathology. 189(12). 2377–2388. 18 indexed citations

10.

Schmidt, Linnéa, Christa Haldrup, Siri H. Strand, et al.. (2018). Exploring the transcriptome of hormone-naive multifocal prostate cancer and matched lymph node metastases. British Journal of Cancer. 119(12). 1527–1537. 11 indexed citations

11.

Schmidt, Linnéa, Jacob Fredsøe, Helle Kristensen, et al.. (2018). Training and validation of a novel 4-miRNA ratio model (MiCaP) for prediction of postoperative outcome in prostate cancer patients. Annals of Oncology. 29(9). 2003–2009. 29 indexed citations

12.

Strand, Siri H., et al.. (2018). Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer. Clinical Epigenetics. 10(1). 105–105. 45 indexed citations

13.

Haldrup, Christa, Nadia Øgaard, Siri H. Strand, et al.. (2018). Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies. Molecular Oncology. 12(4). 545–560. 53 indexed citations

14.

Strand, Siri H., Kamilla Mundbjerg, Gangning Liang, et al.. (2017). Heterogeneous patterns of DNA methylation-based field effects in histologically normal prostate tissue from cancer patients. Scientific Reports. 7(1). 40636–40636. 28 indexed citations

15.

Strand, Siri H., Christa Haldrup, Jakob Hedegaard, et al.. (2016). RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy. Oncotarget. 8(4). 5774–5788. 21 indexed citations

16.

Strand, Siri H., S. Høyer, Christa Haldrup, et al.. (2015). High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancer. Clinical Epigenetics. 7(1). 111–111. 28 indexed citations

17.

Kristensen, Helle, Christa Haldrup, Siri H. Strand, et al.. (2014). Hypermethylation of the GABRE∼miR-452∼miR-224 Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical Prostatectomy. Clinical Cancer Research. 20(8). 2169–2181. 73 indexed citations

18.

Strand, Siri H., Torben Ørntoft, & Karina D. Sørensen. (2014). Prognostic DNA Methylation Markers for Prostate Cancer. International Journal of Molecular Sciences. 15(9). 16544–16576. 86 indexed citations

19.

Sørensen, Karina D., Christa Haldrup, Benedicte P. Ulhøi, et al.. (2013). Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer. British Journal of Cancer. 108(2). 420–428. 47 indexed citations

20.

Schuchmann, Marcus, Henning Schulze‐Bergkamen, Jörn M. Schattenberg, et al.. (2006). Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapy. Oncology Reports. 15(1). 227–30. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact